TC
Tang Capital Management LLC disclosed a 6% stake in SKYE
Tang Capital Management LLC reported owning 6% of Skye Bioscience, Inc. (SKYE) (263,560 shares) in a Schedule 13G filed Oct 14, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.